Navigation Links
Rcadia Medical Imaging Closes $3.3 Million Investment Led by BioVentures Investors
Date:12/15/2008

BOSTON, Dec. 15 /PRNewswire/ -- Rcadia Medical Imaging, Ltd., developer of the COR Analyzer(TM) software for the automated analysis of coronary CT angiography (CCTA) studies, has closed a $3.3M investment round led by BioVentures Investors of Cambridge, MA, Rcadia announced today. Existing investors, including 20/20 HealthCare Partners, also participated in the financing.

Developed by leading Israeli image processing scientists, the COR Analyzer(TM) enables rapid and effective triage of chest pain patients. Immediately after a Coronary CTA study, the COR Analayzer(TM) identifies patients who need further evaluation for severe coronary artery disease, versus those who can be safely discharged. While improving emergency department (ED) workflow, the Rcadia application also can lead to more rapid diagnosis, enabling appropriate treatments and avoiding unnecessary delays for patients without coronary artery disease.

Shai Levanon, Rcadia President and CEO, said that the proceeds of the financing will fund the full commercial launch of the COR Analyzer(TM) and the establishment of a U.S. office to support North American sales and marketing.

"We are extremely pleased to be partnering with BioVentures Investors in this financing round," commented Hillel Bachrach, Executive Chairman of the Board of Directors and Managing Partner at 20/20 HealthCare Partners. "BioVentures has unique expertise in the commercial development of advanced technology in the life sciences." (www.bioventuresinvestors.com)

Simultaneous with the financing, Peter Feinstein, General Partner, BioVentures Investors, and Alex Norbash, M.D., Chairman of Radiology, Boston University Medical Campus, have joined Rcadia's board of directors.

About Rcadia Medical Imaging

Rcadia Medical Imaging is the principal developer of automatic image processing software products for blood vessel analysis. The company's FDA cleared COR Analyzer(TM) performs analysis of Coronary CT angiography (CCTA) studies and automatically without human intervention identifies severe lesions in the main coronaries. The COR Analyzer(TM) is aimed at triaging patients in the ED, improving workflow in the radiology and cardiology departments and serving as 'second eye reader' to prevent miss-reading of severe lesions in CCTA studies. (www.rcadia.com)

About BioVentures Investors

BioVentures Investors, based in Cambridge, Massachusetts, has three venture funds focused on the commercial development of advanced technology in life sciences and healthcare. The three general partners have all been CEOs of companies active in the life sciences and healthcare industry. BioVentures currently has over $145 million under management. (www.bioventuresinvestors.com)

About 20/20 HealthCare Partners

20/20 HealthCare Partners LLC (20/20HCP) is a Boston-based partnership providing management services and equity financing for medical device companies with promising growth potential. 20/20HCP's unique focus is on diagnostic imaging and diagnostic image enhancement applications as well as on the evolution of diagnostic imaging in personalized medicine. 20/20HCP establishes a structure and strategic partnerships for the early identification of opportunities, as well as expedites opportunity development through nimble management and short product development cycles. (www.2020hcp.com)


'/>"/>
SOURCE Rcadia Medical Imaging, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders
2. New research provides dynamic visualization of simplest circadian clock
3. New approach sheds light on ways Circadian disruption affects human health
4. Circadian Rhythm Plays Role in Memory
5. Dont Disturb Your Circadian Rhythm This Black Friday Sleep In, Nap Later, says Specialty Sleep Association
6. MSU engineering team designs innovative medical device
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
9. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
10. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
11. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... 2017 , ... Maury Regional Health has announced a large-scale adoption of AccuVein ... devices, Maury Regional Medical Center is making vein visualization part of their standard of ... and more importantly, helps our staff members locate a vein that will provide good ...
(Date:8/16/2017)... ... 16, 2017 , ... A global leader in the treatment of clubfoot, ... 29 Indian states—bringing the country one step closer to eliminating clubfoot as a lifelong ... is on track to enroll 10,000 children in the clubfoot treatment program in this ...
(Date:8/16/2017)... ... ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has announced ... in a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their content ... disc in 2018. Proceeds will be going to further health research. , Fusion ...
(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class ... . , The healthcare industry in the United States has undergone major changes over ... of needing to have a doctor’s order to get a blood test or other ...
(Date:8/16/2017)... , ... August 16, 2017 , ... First Choice ... States, named Dr. Douglas J. Harrison, as the new Medical Director of its Sienna ... new facility Medical Director of our Sienna Plantation location,” said Dr. Michael (Derek) Caraway, ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... Sancilio Pharmaceuticals Company, Inc. (SPCI) today announced ... Altemia TM , an oral therapy for pediatric patients ... (SCD). The SCOT Trial, is a double-blind, placebo-controlled, dose-finding, ... Altemia TM in pediatric patients aged 5-17 years ... "The completion of ...
(Date:7/25/2017)... and CAMBRIDGE, Massachusetts , July ... specializing in repurposing drugs to treat rare nervous system diseases, ... to clinically develop and market the drug SOM0226 against transthyretin ... drug achieved very promising results in a Phase 2 study ... A new office in the United States ...
Breaking Medicine Technology: